Our Brands

Navinci specializes in developing innovative solutions for the study of protein interactions. With a focus and a strong legacy in the development of proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.

The Naveni Proximity Ligation Technology is at the forefront of innovation within the field of spatial proteomics and allows for the detection and quantification of protein interactions and post-translational modifications in a manner that is both sensitive and specific. It provides researchers with a valuable tool for their studies and helps deepen the understanding of the interplay between proteins in their native environment.

Bioskryb has ushered in a whole new era of single-cell whole genome amplification. The benefits of the BioSkryb ResolveDNA® technology include the ability to control the amplicon size during amplification. This allows the incorporation of barcode identifiers into each sample template, enabling unparalleled reproducibility and sensitive detection of DNA lesions. The complete workflow solution is especially useful in cancer research as it allows the detection of single resistant mutant cells (MRD) in heterogeneous cancers such as leukemia. It also enables new applications for gene sequencing that need a level of resolution simply not available today.

Unchained Labs is committed to provide products that will make a real difference in the research that scientists do every day. They offer solutions for biologics such as screening for stability and aggregation, measuring concentration, buffer exchange and clean up. These capabilities have been further applied to cell and gene therapy workflow by including solutions for viruses and nanoparticles with DNA or RNA.

Uncle is their All-In-One Biologics Stability Platform. UNcle can make multiple measurements from the same sample, combining fluorescence, SLS and DLS reads in one machine. This allows researchers to quickly and efficiently characterize all the size, aggregation, thermal ramp, isothermal and viscosity information in as many as 48 protein constructs and formation simultaneously.

Parse Biosciences Inc., based in Seattle WA, is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. This latest innovation in single cell genomics allows for unprecedented scale without the limitations of microfluidic droplet-based approaches.

Single cell sequencing has already enabled ground-breaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. Parse Biosciences has introduced pioneering technology using combinatorial cDNA barcoding within cells themselves, without a need for cell partitioning instruments. Demonstrating the clear ability to scale, Parse Bio has recently introduced their Evercode Mega Assay for uniquely coding up to a million cells per sample.

LevitasBio has developed the first truly novel approach to cellular analysis in 30 years with a powerful method of cellular analysis. This label-free magnetic levitation technology enables researchers to rescue and achieve higher quality and quantity of cells without introducing bias, high pressure, and modifications to gene expression profiles, thus ensuring the integrity of downstream data and analysis.

Using Magnetic Levitation Technology, LevitasBio’s instruments and assay kits leverage the power of levitation to accurately detect, quantify, enrich and test cells. This label-free unbiased and gentle technique requires minimal time and handling, creating a truly game-changing tool for advancing the fields of Immunology, Oncology, Stem Cells, Large Cell/ Organoid, Single Cell Sequencing, Bacteriology Infectious diseases and more.

Cell Signaling Technology is a private company founded by scientists and dedicated to providing high quality research tools to the biomedical research community. CST develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Well known for their mission to produce in-house and rigorously validate every product they make to assure dependable performance – CST are adamant about making the highest quality, most consistent antibodies that work the first time, and every time. All CST antibodies go thru in-house Antibody validation, application testing, optimized target selection and are provided together with a performance guarantee and dilution and optimization protocols.

CST maintains an in-house research program, particularly in the area of cancer research, and has published scientific papers in many peer-reviewed journals. In addition to product development and production, CST is also involved in the development of new technologies for signaling analysis as well as mechanistic cell biology research, particularly in the field of cancer research. CST also curates and maintains PhosphoSitePlus, a web-based bioinformatics resource that details post-translational modifications (PTMs) in human, mouse and rat proteins.

Mission Bio is helping researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine. Mission Bio’s Tapestri Platform is the only system capable of simultaneously providing both genotype and phenotype data from the same cell, across thousands of single cells. With DNA as a foundation, MB’s proprietary two-step microfluidic workflow enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins. The Tapestri single-cell DNA panels and protein panels are highly sensitive and customizable panels that enable true multi-omics analysis for identifying co-mutation patterns and zygosity in subclones, or cellular identities and subtle cell states and are applied across a wide range of discovery and translational research applications. Meet the complexity of cancer with true multi-omics analysis.

ProteinTech is the benchmark for manufacturing original antibodies. With an emphasis on developing antibodies from whole proteins, ProteinTech provides researchers with unmatched reliability and reproducibility. Founded by scientists in 2001 after their continued frustration with failed experiments due to low-grade antibodies, ProteinTech is on a path to foster better science by producing the highest quality antibodies for every human protein.

ChromoTek, now a part of Proteintech inc., pioneered the development and commercialization of Nanobody-based research reagents. They are the global market and product leader for high quality and reliable Nanobody-based reagents, which assist our customers’ research. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry.

MGI Tech Co., Ltd. (MGI), is committed to building core tools and technology in life science through innovation. With a focus on R&D, production and sales of DNA sequencing instruments and reagents supporting life science research, agriculture and healthcare, MGI has become a leader in the production of clinical high-throughput gene sequencers.

With support in over 50 countries world-wide including sales, R&D, production and global training sites MGI has a comprehensive support network for all of its users.

A continuing development of new instruments and technology ensure MGI are ahead of the ever increasing demands and application areas customers are demanding in the Life-science market.

Quanterix has developed an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. The Single Molecule Array (Simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. Quanterix is the exclusive licensee of a broad intellectual property portfolio initially developed at Tufts University by Dr. David Walt, scientific founder of Quanterix and Illumina.

Twist Bioscience has revolutionized synthetic DNA manufacturing by developing a silicon-based DNA Synthesis Platform to address the limitations of throughput, scalability and cost inherent in legacy DNA synthesis methods. Applying rigorous engineering and AI principles to harness the highly scalable production allowing semiconductor level precision in manufacturing DNA at scale. Twist has industrialized the production of cost-effective, high-fidelity, high-throughput DNA, for a range of NGS panels, Genes, Oligo Pools, Custom Libraries and Variant Libraries, all tailored precisely for your experiment.

Fluxion Biosciences was founded in 2005 in San Francisco, California in the USA with its principal focus on analytical instruments for functional cellular analyses. In 2008, BioFlux 200 was the recipient of the R&D 100 Award given by R&D Magazine to the top 100 new technologies of the year. In 2010 and 2013, Fluxion received additional R&D 100 awards for the IonFlux HT System and IsoFlux System, respectively. In addition to its core product lines, Fluxion is also engaged in cutting-edge research to produce the next generation of breakthrough technologies.

Axel Semrau has been active for more than 35 years in the development, distribution and support for the automation of sample preparation and chromatography, chemical synthesis as well as application optimized workstations. AS develops its own hardware and software in order to be able to provide unique and robust solutions in chromatography providing total solution, application based lab automation sample prep and analysis systems for application such as Mineral oils (MOSH/MOAH), PAHs, Sterols, and Glyphosate in Foods, as well as protein extraction, Fatty Acid Methyl Esters (FAME) and more.

CTC Analytics is a Swiss company at the forefront of automation for gas and liquid chromatography with their PAL System series of lab automation systems and with over 30 years of continuous development and improvement.  This flexible, highly reliable, advanced laboratory sample handling platform is widely adopted in the pharmaceutical, life science, chemical, environmental and food & flavor industries.   The PAL Systems robotic systems have a flexible modular design, allowing the worldwide customer base to create their own customized solution to respond to their individual needs to increase productivity, accuracy, reliability and traceability.

BIOER, with origins in pioneering and manufacturing precision Peltier cooling systems, now design and produce some of the finest and most durable Peltier based instruments for life science research. In 1998, Bioer launched China’s first semiconductor-based (Peltier) PCR system. Bioer is the leading manufacturer of PCR systems in China, offering some of the world’s finest thermal cyclers for PCR and Real Time PCR, as well water baths, Dry Baths, NA Extraction, and a range of quality genomic and kits.

Seahorse, now part of Agilent, is known for their XF Analyzers used to measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of live cells in a multi-well plate, interrogating key cellular functions such as mitochondrial respiration and glycolysis. XF Analyzers perform compound addition and mixing, label-free analytical detection, and automatic measurement of OCR and ECAR in real time. Also under Seahorse are the MiToXpress and pH-Xtra plate reader assays, easy to use kits for measuring real-time energy flux, mitochondrial function, glycolysis and substrate utilization in living cells, isolated mitochondria, 3D cultures, and microbes.

CODEX DNA, Inc., Formerly known as SGI-DNA, and founded by Dan Gibson — the creator of the industry-standard Gibson Assembly® methodology, CODEX offers Synthetic DNA on demand. CODEX is on a mission to empower scientific researchers to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology.  CODEX is decentralizing DNA synthesis with the world's most innovative portfolio of synthetic biology platform technologies.  Their gene synthesis portfolio reduces the turnaround time for synthesizing biology workflows from weeks and months down to days and hours and includes the BioXp™ 3200 system (the world's first and only gene printer), variant library services, and Gibson Assembly® reagents.   In addition to automating, speeding, and optimizing DNA design and synthesis, CODEX and the BioXp™ system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, DNA data storage, and beyond.